Published in J Thorac Cardiovasc Surg on June 01, 2009
The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry(®). Catheter Cardiovasc Interv (2016) 1.48
Closure of interatrial defects by immediate-release patch. Pediatr Cardiol (2012) 1.37
Surgical repair after ineffective device closure of an inferior sinus venosus defect. Interact Cardiovasc Thorac Surg (2012) 0.93
Very late cardiac tamponade following successful transcatheter closure of an atrial septal defect with the Amplatzer septal occluder. Clin Res Cardiol (2015) 0.92
Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these changes while using transesophageal echocardiography or intracardiac echocardiography? Pediatr Cardiol (2012) 0.86
Intermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients. Ann Pediatr Cardiol (2011) 0.86
Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects. Pediatr Cardiol (2014) 0.85
Risk factors and prognosis of atrioventricular block after atrial septum defect closure using the Amplatzer device. Pediatr Cardiol (2013) 0.81
Device closure of secundum atrial septal defect's and the risk of cardiac erosion. Echo Res Pract (2015) 0.79
Impact of the Amplatzer atrial septal occluder device on left ventricular function in pediatric patients. Pediatr Cardiol (2013) 0.79
Cardiac tamponade due to perforation by an Amplatzer atrial septal occluder in a patient with Marfan syndrome. J Artif Organs (2011) 0.76
Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs. J Artif Organs (2012) 0.76
Successful Percutaneous Retrieval of Embolized Septal Occluder Device from Aortic Arch and Placement of a Newer Septal Occluder Device in Combined Procedure. Case Rep Cardiol (2016) 0.75
Atrioventricular block after ASD closure. Heart Asia (2016) 0.75
Endocarditis and Incomplete Endothelialization 12 Years after Amplatzer Septal Occluder Deployment. Tex Heart Inst J (2016) 0.75
Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder. J Biomed Biotechnol (2012) 0.75
Post-market surveillance to detect adverse events associated with Melody® valve implantation. Cardiol Young (2016) 0.75
Clarification of statements made regarding investigation into Amplatzer device complication incidence and comparison with the Society of Thoracic Surgery database. J Thorac Cardiovasc Surg (2009) 0.75
Surgical treatment of amplatzer embolus in a secundum atrial septal defect patient. J Tehran Heart Cent (2012) 0.75
Coronary Sinus Defect Following Transcatheter Closure of ASD Using Amplatzer Septal Occluder: Potential Erosion by the Device. Pediatr Cardiol (2017) 0.75
Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure. Pediatr Cardiol (2015) 0.75
Anterior Minithoracotomy: a Safe Approach for Surgical ASD Closure & ASD Device Retrieval. Braz J Cardiovasc Surg (2017) 0.75
Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol (2002) 6.01
Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol (2004) 5.44
Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol (2002) 5.41
Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv (2004) 3.13
Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv (2004) 3.08
Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol (2005) 1.52
Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol (2004) 1.33
Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc Interv (2003) 1.26
Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer Septal Occluder. Am Heart J (2004) 1.07
Migration of an amplatzer septal occluder device for closure of atrial septal defect into the ascending aorta with formation of an aorta-to-right atrial fistula. Am J Cardiol (2005) 1.05
Medical device vigilance at FDA. Stud Health Technol Inform (1996) 1.00
Major complications associated with transcatheter atrial septal occluder implantation: a review of the medical literature and the manufacturer and user facility device experience (MAUDE) database. Congenit Heart Dis (2008) 0.97
Late cardiac perforation following transcatheter atrial septal defect closure. Ann Thorac Surg (2004) 0.97
CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects. Am Heart J (2004) 0.95
Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg (2006) 0.93
Part I: Identifying holes in the safety net. Am Heart J (2004) 0.91
Part II: Sealing holes in the safety net. Am Heart J (2004) 0.89
Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv (2003) 0.87
Cardiac perforation 6 weeks after percutaneous atrial septal defect repair using an Amplatzer septal occluder. Pediatrics (2006) 0.86
Embolic stroke due to a left atrial thrombus two years after placement of an atrial septal defect closure device. Am J Cardiol (2006) 0.84
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation (2007) 4.36
Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit. Pediatr Crit Care Med (2006) 2.77
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics (2007) 2.47
Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation (2006) 2.35
Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. Ann Thorac Surg (2010) 2.24
Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operations. Ann Thorac Surg (2012) 2.22
Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation (2009) 2.22
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04
Sudden unexpected death after balloon valvuloplasty for congenital aortic stenosis. J Am Coll Cardiol (2010) 2.02
From stem cells to viable autologous semilunar heart valve. Circulation (2005) 1.94
Aortico-left ventricular tunnel: 35-year experience. J Am Coll Cardiol (2004) 1.93
Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg (2002) 1.91
Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol (2009) 1.86
Report of the 2010 society of thoracic surgeons congenital heart surgery practice and manpower survey. Ann Thorac Surg (2011) 1.76
Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76
Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience. Circulation (2006) 1.75
Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol (2011) 1.74
Aortic valvuloplasty in the fetus: technical characteristics of successful balloon dilation. J Pediatr (2005) 1.73
The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg (2003) 1.69
Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg (2008) 1.69
Characterization of radiation exposure and effect of a radiation monitoring policy in a large volume pediatric cardiac catheterization lab. Catheter Cardiovasc Interv (2011) 1.63
Long-term pulmonary regurgitation following balloon valvuloplasty for pulmonary stenosis risk factors and relationship to exercise capacity and ventricular volume and function. J Am Coll Cardiol (2010) 1.60
Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum: a case-matched study. Ann Thorac Surg (2011) 1.60
Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol (2004) 1.59
Percutaneous left atrial decompression in patients supported with extracorporeal membrane oxygenation for cardiac disease. Pediatr Crit Care Med (2015) 1.58
Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. Ann Thorac Surg (2011) 1.58
The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg (2008) 1.56
Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg (2005) 1.55
Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng (2009) 1.54
Congenital heart surgery databases around the world: do we need a global database? Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2010) 1.50
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation (2012) 1.50
Factors associated with subsequent arch reintervention after initial balloon aortoplasty in patients with Norwood procedure and arch obstruction. J Am Coll Cardiol (2011) 1.49
Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv (2011) 1.47
Variation in outcomes for risk-stratified pediatric cardiac surgical operations: an analysis of the STS Congenital Heart Surgery Database. Ann Thorac Surg (2012) 1.46
Quality measures for congenital and pediatric cardiac surgery. World J Pediatr Congenit Heart Surg (2012) 1.45
A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg (2005) 1.45
Public reporting of healthcare data: a new frontier in quality improvement. Bull Am Coll Surg (2012) 1.45
Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg (2004) 1.44
Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database. J Heart Lung Transplant (2009) 1.42
Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation (2004) 1.39
Exploring the Role of Polycythemia in Patients With Cyanosis After Palliative Congenital Heart Surgery. Pediatr Crit Care Med (2016) 1.39
Pulmonary deadspace and postoperative outcomes in neonates undergoing stage 1 palliation operation for single ventricle heart disease. Pediatr Crit Care Med (2014) 1.39
Physician payment for 2007: a description of the process by which major changes in valuation of cardiothoracic surgical procedures occurred. Ann Thorac Surg (2007) 1.39
Right ventricle to pulmonary artery conduit augmentation compared with replacement in young children. Ann Thorac Surg (2009) 1.39
Surgical management of neonatal atrioventricular septal defect with aortic arch obstruction. Ann Thorac Surg (2013) 1.39
Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. Biomaterials (2006) 1.38
Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med (2013) 1.37
The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials (2005) 1.36
Regional low-flow perfusion versus circulatory arrest in neonates: one-year neurodevelopmental outcome. Ann Thorac Surg (2006) 1.36
A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials (2003) 1.34
Early repair of hemitruncus: excellent early and late outcomes. J Thorac Cardiovasc Surg (2007) 1.33
Validation and re-evaluation of a discriminant model predicting anatomic suitability for biventricular repair in neonates with aortic stenosis. J Am Coll Cardiol (2006) 1.32
To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis (2010) 1.31
Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol (2003) 1.30
Measurement of technical performance in congenital heart surgery: a pilot study. Ann Thorac Surg (2007) 1.27
Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg (2007) 1.27
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg (2008) 1.26
Factors associated with prolonged recovery after the fontan operation. Circulation (2008) 1.25
Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine. FASEB J (2009) 1.23
Variation in congenital heart surgery costs across hospitals. Pediatrics (2014) 1.22
The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials (2009) 1.19
Outcomes after bidirectional Glenn operation: Blalock-Taussig shunt versus right ventricle-to-pulmonary artery conduit. Ann Thorac Surg (2007) 1.17
Variation in perioperative care across centers for infants undergoing the Norwood procedure. J Thorac Cardiovasc Surg (2012) 1.16
Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome. Prenat Diagn (2008) 1.16
Incorporation of the hepatic veins into the cavopulmonary circulation in patients with heterotaxy and pulmonary arteriovenous malformations after a Kawashima procedure. Ann Thorac Surg (2005) 1.14
Heart valve regeneration. Adv Biochem Eng Biotechnol (2005) 1.13
Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis (2002) 1.13
Surgical outcome for patients with the mitral stenosis-aortic atresia variant of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (2007) 1.13
Long-term outcome of surgically treated patients with corrected transposition of the great arteries. J Thorac Cardiovasc Surg (2005) 1.12
Coarctectomy reduces neoaortic arch obstruction in hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (2007) 1.12
Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann Biomed Eng (2004) 1.11
Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation (2004) 1.11
Guidance of engineered tissue collagen orientation by large-scale scaffold microstructures. J Biomech (2005) 1.09
Liver disease in the patient with Fontan circulation. Congenit Heart Dis (2011) 1.08
Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation (2012) 1.08
Analysis of surgical outcome in complex double-outlet right ventricle with heterotaxy syndrome or complete atrioventricular canal defect. Ann Thorac Surg (2006) 1.08
Causes of death after congenital heart surgery. Ann Thorac Surg (2007) 1.07
Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail (2009) 1.06
Short-term performance of the transcatheter Melody valve in high-pressure hemodynamic environments in the pulmonary and systemic circulations. Circ Cardiovasc Interv (2011) 1.06
Outcome after reconstruction of discontinuous pulmonary arteries. J Thorac Cardiovasc Surg (2002) 1.06
Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol (2002) 1.06
Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds. Circulation (2006) 1.06
Improving results of the modified Fontan operation in patients with heterotaxy syndrome. Ann Thorac Surg (2002) 1.05
Reversible ductus arteriosus constriction due to maternal indomethacin after fetal intervention for hypoplastic left heart syndrome with intact/restrictive atrial septum. Fetal Diagn Ther (2009) 1.03
Primary left ventricular rehabilitation is effective in maintaining two-ventricle physiology in the borderline left heart. J Thorac Cardiovasc Surg (2009) 1.03
Functional collagen fiber architecture of the pulmonary heart valve cusp. Ann Thorac Surg (2009) 1.03
Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation (2004) 1.02
Long-term results of right ventricular outflow tract reconstruction in neonatal cardiac surgery: options and outcomes. J Thorac Cardiovasc Surg (2009) 1.02
Pathophysiology, management, and outcomes of fetal hemodynamic instability during prenatal cardiac intervention. Pediatr Res (2007) 1.02
Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interv (2013) 1.02
In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg (2010) 1.02
Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg (2009) 1.02
Neo-aortic root dilation and valve regurgitation up to 21 years after staged reconstruction for hypoplastic left heart syndrome. J Am Coll Cardiol (2003) 1.01
Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum. Pediatrics (2006) 1.01
Serial cardiopulmonary exercise testing in patients with previous Fontan surgery. Pediatr Cardiol (2010) 1.01
Aortic valve reinterventions after balloon aortic valvuloplasty for congenital aortic stenosis intermediate and late follow-up. J Am Coll Cardiol (2010) 1.00